Therapeutic strategies to maintain body mass within third centile of BMI-SDS ranges should be developed in order to prolong C-peptide, hence endogenous insulin secretion in new onset type 1 diabetes in children. This evidence concerns the gene INS and type 1 diabetes mellitus.